A Multicenter, Randomized, Phase 2, Double-blind, Vehicle-controlled, Parallel Group Comparison Study to Evaluate the Safety and Efficacy of Q301 Cream in Adolescents and Adults With Mild to Moderate Atopic Dermatitis
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2018
At a glance
- Drugs Q 301 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Qurient Co
- 23 Oct 2018 Planned End Date changed from 1 Nov 2019 to 1 Dec 2019.
- 23 Oct 2018 Planned primary completion date changed from 1 Aug 2019 to 1 Oct 2019.
- 23 Oct 2018 Status changed from not yet recruiting to recruiting.